Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

N, Sprigg; K, Flaherty; JP, Appleton; Salman R, Al-Shahi; D, Bereczki; M, Beridze; H, Christensen; A, Ciccone; R, Collins; A, Czlonkowska; RA, Dineen; L, Duley; JJ, Egea-Guerrero; TJ, England; K, Krishnan; AC, Laska; ZK, Law; S, Ozturk; SJ, Pocock; I, Roberts; TG, Robinson; C, Roffe; D, Seiffge; P, Scutt; J, Thanabalan; D, Werring; D, Whynes; PM, Bath

doi:10.1016/s0140-6736(18)31033-x

Public

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

Shared by NobleBlocks on May 16, 2018 • 12:00 AM UTC

Authors:

Sprigg N

Flaherty K

Appleton JP

Abstract

<h4>Background</h4>Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage.<h4>Methods</h4>We did an international, r...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!